Picard Medical Inc(PMI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -20.65 | Insider Own | 39.84% | Shs Outstand | 2.1M | Perf Week | 33.44% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 1.5M | Perf Month | 48.44% |
| Enterprise Value | 0.02B | PEG | - | EPS next Q | - | Inst Own | 6.03% | Short Float | 3.47% | Perf Quarter | 99.53% |
| Income | -0.03B | P/S | 3.35 | EPS this Y | - | Inst Trans | 10.16% | Short Ratio | 0.03 | Perf Half Y | -51.26% |
| Sales | 0.01B | P/B | 10.28 | EPS next 5Y | - | ROA | -268.26% | Short Interest | 0.05M | Perf YTD | -90.19% |
| Book/sh | 0.83 | P/C | 527.39 | EPS past 3/5Y | -27.88% - | ROE | - | 52W High | -95.88% ($208.00) | Perf Year | -93.76% |
| Cash/sh | 0.02 | P/FCF | - | Sales past 3/5Y | 6.3% - | ROIC | -1631.29% | 52W Low | 223.53% ($2.65) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 0.82% | Gross Margin | 17.9% | Volatility(W/M) | 11.05% 30.17% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 3.59 | Sales Y/Y TTM | 41% | Oper. Margin | -248.1% | ATR (14) | 2.03 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.22 | EPS Q/Q | 40.21% | Profit Margin | -444.33% | RSI (14) | 50.91 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.02 | Sales Q/Q | 38.62% | SMA20 | -11.96% ($9.75) | Beta | -2.76 | Target Price | - |
| Payout | - | Debt/Eq | 0.92 | Earnings | 2026/8/20 | SMA50 | 17.73% ($7.29) | Rel Volume | 0.03 | Prev Close | $8.35 |
| Employees | 75 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -103.33% 90.58% | SMA200 | -71.44% ($30.04) | Avg Volume(3M) | 1.63M | Price | $8.58 |
| IPO | 2025/8/29 | Option/Short | No/Yes | Trades | 397 | Volume | 41,479 | Change | 2.75% |
🫀 Through its subsidiary SynCardia, the company is a U.S. innovative medical device maker that holds the world's only approved total artificial heart (TAH) technology. It provides a unique life-sustaining solution for end-stage heart failure patients, keeping them alive until they can receive a heart transplant.
Over the past 1 year, on the lower side
96% below its 1-year high.
Traded less than usual. That is 3% of its average volume.
PMI has weak earnings and a weak balance sheet
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $335. Peers typically go for $145.
Tap to view numbers
Not enough quarters to judge yet
Only 1 quarter(s) reported, so no grade yet.
Tap to view numbers
Holding long would have lost money
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 6.0%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #107 of 140 in the industry
Based on market cap of $21M.
NSPR#105 InspireMD Inc $25M PER - 
NNOX#106 Nano X Imaging Ltd $24M PER - PMI#107 Picard Medical Inc $21M PER - 
ARAY#108 Accuray Inc $18M PER - 
ITOC#109 iTonic Holdings Ltd $17M PER - 
FAQ
What kind of company is PMI?
PMI belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of PMI?
The market cap of PMI is approximately $21M, ranking 5,190 within its sector.
What is the 52-week high and low for PMI?
PMI has recorded a 52-week high of $208.00 and a low of $2.65.
